Osteopenia Unknown Status Phase 2 Trials for Teriparatide (DB06285)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01604057Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone MassTreatment